Detection and incidence of drug-induced agranulocytosis in hospital: a prospective analysis from laboratory signals

被引：0
|
作者：
N. Tavassoli
E. Duchayne
B. Sadaba
K. Desboeuf
A. Sommet
M. Lapeyre-Mestre
M. J. Muoz
P. Sie
J. Honorato
J. L. Montastruc
H. Bagheri
机构：
[1] Université Paul Sabatier,Laboratoire de Pharmacologie Médicale et Clinique, Centre Midi
[2] Faculté de Médecine,Pyrénées de Pharmacovigilance, de Pharmacoépidémiologie et d’informations sur le Médicament, Unité de Pharmacoépidémiologie EA 3696
[3] Hôpital Purpan,Laboratoire d’Hématologie, Centre Hospitalier Universitaire
[4] University Hospital of Navarra,Department of Clinical Pharmacology
[5] Centre Hospitalier Universitaire,Département d’information médicale
[6] Université Paul Sabatier,Service de Pharmacologie Clinique
[7] Faculté de Médecine,undefined
来源：
European Journal of Clinical Pharmacology | 2007年 / 63卷
关键词：
Drug-induced agranulocytosis; Laboratory monitoring; Underreporting rate; Pharmacovigilance;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] Detection of drug safety signal of drug-induced neutropenia and agranulocytosis in all-aged patients using electronic medical records
    Sun, Cuicui
    Zhao, Lixia
    Yuan, Yujie
    Xiang, Yanxiao
    Liu, Anchang
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 (04) : 416 - 425
  • [22] Prognostic factors of hematologic recovery in non-chemotherapy drug-induced agranulocytosis
    Maloisel, F
    Andrès, A
    Kaltenbach, G
    Noel, E
    Koumarianou, A
    HAEMATOLOGICA, 2003, 88 (04) : 470 - 471
  • [23] Characterisation of Drug-Induced Liver Injury in Patients with COVID-19 Detected by a Proactive Pharmacovigilance Program from Laboratory Signals
    Delgado, Ana
    Stewart, Stefan
    Urroz, Mikel
    Rodriguez, Amelia
    Borobia, Alberto M.
    Akatbach-Bousaid, Ibtissam
    Gonzalez-Munoz, Miguel
    Ramirez, Elena
    JOURNAL OF CLINICAL MEDICINE, 2021, 10 (19)
  • [24] DRUG-INDUCED AGRANULOCYTOSIS TREATED WITH GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR
    HURTADO, R
    CANDELARIA, M
    MAJLUFCRUZ, A
    SOSACAMAS, RE
    LABARDINIMENDEZ, J
    REVISTA DE INVESTIGACION CLINICA-CLINICAL AND TRANSLATIONAL INVESTIGATION, 1994, 46 (01): : 59 - 61
  • [25] A strategy to improve the detection of drug-induced hepatotoxicity
    Montero, AR
    Quintana, JAD
    Sáenz, MJ
    Delgado, JAA
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2005, 97 (03) : 155 - 157
  • [26] Non-Chemotherapy-Induced Agranulocytosis Detected by a Prospective Pharmacovigilance Program in a Tertiary Hospital
    Medrano-Casique, Nicolas
    Tong, Hoi Y.
    Borobia, Alberto M.
    Carcas, Antonio J.
    Frias, Jesus
    Ramirez, Elena
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2015, 117 (06) : 399 - 408
  • [27] Drug-induced diseases (DIDs): An experience of a tertiary care teaching hospital from India
    Tandon, Vishal R.
    Khajuria, Vijay
    Mahajan, Vivek
    Sharma, Aman
    Gillani, Zahid
    Mahajan, Annil
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2015, 142 : 33 - 39
  • [28] Clinical Pattern and Causality Assessment of Drug-induced Cutaneous Reactions in a Tertiary Care Hospital in India: A Prospective Study
    James, Jerin
    Mohamed, Althab B.
    Hussain, Fayaz S.
    Rani, Jamuna
    Varadarajan, Sathyanarayanan
    CURRENT DRUG SAFETY, 2022, 17 (03) : 193 - 198
  • [29] Comparison of hospital episodes with 'drug-induced' disorders and spontaneously reported adverse drug reactions
    Barrow, P
    Waller, P
    Wise, L
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2006, 61 (02) : 233 - 237
  • [30] EFFECTIVE TREATMENT OF DRUG-INDUCED AGRANULOCYTOSIS USING RECOMBINANT HUMAN GRANULOCYTE-COLONY-STIMULATING FACTOR IN PREGNANCY
    FUJIWAKI, R
    HATA, T
    HATA, K
    KITAO, M
    FURUYA, H
    KATOH, Y
    GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 1995, 40 (04) : 276 - 277
12345